Publications by authors named "Shusei Fusayasu"
Article Synopsis
- A rare case was reported where a 71-year-old man with advanced prostate cancer showed simultaneous presence of a BRCA2 mutation and microsatellite instability-high (MSI-high) status.
- Following various treatments including hormone therapy and docetaxel, the patient's cancer progressed, leading to the introduction of pembrolizumab.
- Remarkably, after two months of pembrolizumab treatment, the patient experienced a significant reduction in prostate-specific antigen (PSA) levels and a complete response to his metastatic lesions, with no adverse effects noted.
Background: Osteoporosis is a common consequence of androgen deprivation therapy (ADT) for prostate cancer. Up to 20 % of men on ADT have suffered from fractures within 5 years. The WHO Fracture Risk Assessment Tool (FRAX) has been utilized to predict the 10-year probability of major osteoporotic and hip fracture.
View Article and Find Full Text PDFA 45-year-old man complained of a palpable mass in his left abdomen. Computed tomography showed a horseshoe kidney with a Bosniak type II complicated cyst from a left segment. Three years after his initial examination, due to the growing cystic lesion and the compression imposed on the urinary collecting system and surrounding organs, we performed a left heminephrectomy.
View Article and Find Full Text PDF